Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
TOAMI, First Half Ordinary Profit Turns to Profit, Jul-Sep Ordinary Profit Turns to Profit
5973 TOAMI CORPORATION 【J-GAAP】
Earnings ReportTOAMI CORPORATION <5973> [TSE Std] announced its financial results after the market closed on November 11th (16:00). The consolidated ordinary profit/loss for the cumulative second quarter of the fiscal year ending March 2026 (April to September) turned into a profit of 120 million yen (compared to a loss of 87 million yen in the same period last year). However, Progress toward the full-year plan of 300 million yen was 40.0%, almost the same as the five-year average of 38.3%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to surge 3.2 times that of the same period last year, reaching 180 million yen.
In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit/loss turned to a profit of 80 million yen (compared to a loss of 58 million yen in the same period last year). The operating profit/loss margin significantly improved from -1.9% in the same period last year to 1.9%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2023 | 8,726 | 115 | 98 | 62 | 10.4 | 29.1 | Nov 8, 2023 | J-GAAP |
| Apr - Sep, 2024 | 8,571 | -137 | -87 | -66 | -11.6 | ー | Nov 12, 2024 | J-GAAP |
| Apr - Sep, 2025 | 9,094 | 104 | 120 | 67 | 11.8 | 40.0 | Nov 11, 2025 | J-GAAP |
| YoY | +6.1% | - | - | - | - |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 Guidance | ー | ー | ー | ー | - | 8 | May 13, 2025 | J-GAAP |
| Apr - Sep, 2025 Results | 9,094 | 104 | 120 | 67 | 11.8 | 8 | Nov 11, 2025 | J-GAAP |
| Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 9,533 | 26 | 57 | 60 | 11.2 | 8 | May 13, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 10,906 | 106 | 180 | 103 | 18.0 | 8 | Nov 11, 2025 | J-GAAP |
| YoY | +14.4% | +307.7% | +215.8% | +71.7% | +60.4% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 17,628 | 324 | 337 | 247 | 41.4 | 15.50 | May 13, 2024 | J-GAAP |
| Mar, 2025 | 18,104 | -111 | -30 | -6 | -1.1 | 16 | May 13, 2025 | J-GAAP |
| Mar, 2026 Guidance | 20,000 | 210 | 300 | 170 | 29.6 | 16 | May 13, 2025 | J-GAAP |
| YoY | +10.5% | - | - | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 4,518 | -86 | -58 | -48 | -8.4 | -1.9 | Nov 12, 2024 | J-GAAP |
| Oct - Dec, 2024 | 5,134 | 61 | 68 | 113 | 20.0 | 1.2 | Feb 10, 2025 | J-GAAP |
| Jan - Mar, 2025 | 4,399 | -35 | -11 | -53 | -9.9 | -0.8 | May 13, 2025 | J-GAAP |
| Apr - Jun, 2025 | 4,582 | 20 | 40 | 14 | 2.5 | 0.4 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 4,512 | 84 | 80 | 53 | 9.3 | 1.9 | Nov 11, 2025 | J-GAAP |
| YoY | -0.1% | - | - | - | - |
Related Articles
Chiome Bioscience, Jan-Sep (Cumulative 3Q) Net Income Loss Narrows, Jul-Sep Net Income Loss Narrows
TEMONA inc, Last Fiscal Year's Ordinary Profit Turns Profitable, Current period performance is undisclosed.
Nippon Chemical, First Half Ordinary Profit Decreases by 43%, Jul-Sep Ordinary Profit Decreases by 63%
VIA Holdings, Ordinary Profit Forecast for the Fiscal Year Revised Downward to an Unexpected 84% Decrease
OHMOTO GUMI, Jul-Sep (2Q) Ordinary Profit Increases by 16%
DAIFUKU, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 13%, Exceeded Record Profit Forecast, Dividend Revised Upward by 8 Yen
KAWADA TECH, First Half Ordinary Profit Decreases by 39%, Jul-Sep Ordinary Profit Decreases by 39%
TOTECH, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 6%, Raises Record High Profit Forecast, Dividend Revised Upward by 13 Yen
airCloset, Jul-Sep (1Q) Ordinary Profit Turns to Loss
TAKARA HOLDINGS, Ordinary Profit Forecast for the Fiscal Year Revised Downward to an Unexpected 29% Decrease